COMMUNIQUÉS West-GlobeNewswire

Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018

16/04/2018 - 15:00

Late-breaking poster demonstrates EC17/CAR T-cell therapy showed consistent antitumor activity in human xenografts with multiple mechanisms for controlling immune response WEST LAFAYETTE, Ind., April 16, 2018 (GLOBE [...]

BeiGene Presents Clinical Data on Pamiparib in Chinese Patients with Ovarian Cancers or Triple-Negative Breast Cancer at the American Association for Cancer Research Annual Meeting

16/04/2018 - 15:00

BEIJING, China and CAMBRIDGE, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]

VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR

16/04/2018 - 15:00

TEL AVIV, Israel, April 16, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ: VBLT ) today presented a late-breaking study demonstrating a novel bi-specific antibody that induces immune-cell mediated killing of cancer [...]

Advantis Corp. Increased Revenue Over Eight Fold in 2017, Expects Revenue to Rise

16/04/2018 - 15:00

NEWPORT BEACH, CA , April 16, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) released its annual financial report, revealing the revenue increase of a company on the rise. 2017 revenue was $406,000 vs. $ [...]

Cannabix Technologies Files FAIMS Cannabis Detection Patent - Enters into License Agreement with University of Florida and Provides Technology Update

16/04/2018 - 14:45

The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. ( [...]

Regalia® CG Biofungicide Cleared for Use on Cannabis by the Colorado, Oregon, Washington and Nevada Departments of Agriculture

16/04/2018 - 14:31

Trials Show Regalia® CG to be an Effective Method of Powdery Mildew Control in Cannabis and Hemp DAVIS, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider [...]

Kallelse till årsstämma för C-RAD AB (publ)

16/04/2018 - 14:30

Aktie ä garna i C-RAD AB (publ), org. nr 556663-9174 ( ” Bolaget ” ), kallas h ä rmed till å rsst ä mma torsdagen den 17 maj 2018 klockan 10.00 p å Clarion Hotel Gillet, Dragarbrunnsgatan 23 i Uppsala. Rätt att deltaga [...]

AIT Therapeutics Names Stephen J. DiPalma as Chief Financial Officer

16/04/2018 - 14:30

Industry veteran brings over 30 years of experience to AIT NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical device and biopharmaceutical company focused on [...]

Alder BioPharmaceuticals® Appoints Erin Lavelle to Newly Created Role of Chief Operating Officer

16/04/2018 - 14:30

Continues to Build Executive Team and Position Company for Next Stage of Growth and Development BOTHELL, Wash., April 16, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ) (“Alder” or the “Company [...]

Cerner to Release First Quarter 2018 Earnings Results May 2

16/04/2018 - 14:30

KANSAS CITY, Mo. , April 16, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN ) today announced it will release its first quarter 2018 earnings results after the market closes Wednesday, May 2. Following the [...]

Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models

16/04/2018 - 14:05

SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today announced that along with its collaborators, it has achieved several breakthrough capabilities for its 3D [...]

Cellectar Presents Preclinical Data at AACR Annual Meeting Demonstrating the Ability of its PDCs to Selectively Target a Broad Range of Tumor Cells

16/04/2018 - 14:05

MADISON, Wis., April 16, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]

Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis

16/04/2018 - 14:00

NORCROSS, Ga., April 16, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today provided highlights from a late-breaker oral [...]

Foamix Announces $16 Million Investment by OrbiMed

16/04/2018 - 14:00

REHOVOT, Israel and BRIDGEWATER, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]

Preclinical Data Highlighting Uptake and Enhanced Anti-Tumor Effects of Cellectar’s CLR 131 in Head and Neck Cancer Presented at AACR Annual Meeting

16/04/2018 - 14:00

MADISON, Wis., April 16, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]

Melinta Therapeutics to Present Detailed Results from Vabomere TANGO II Trial as well as New In Vitro and In Vivo Findings from Baxdela and Pyrrolocytosine Candidate at ECCMID 2018

16/04/2018 - 14:00

NEW HAVEN, Conn., April 16, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]

Spero Therapeutics Highlights SPR741 Phase 1 and Preclinical Data at the 28th European Congress of Clinical Microbiology and Infectious Diseases

16/04/2018 - 14:00

Eight presentations on SPR741 at ECCMID, collectively supporting its activity, safety and tolerability CAMBRIDGE, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset [...]

XBiotech Announces Upcoming Phase 2 Clinical Studies in Dermatology

16/04/2018 - 14:00

XBiotech to Launch Two Phase 2 Clinical Studies to Study Subcutaneous Administration of MABp1 for Treatment of Hidradenitis Suppurativa and Atopic Dermatitis AUSTIN, Texas, April 16, 2018 (GLOBE NEWSWIRE) -- XBiotech [...]

Extendicare Announces April 2018 Dividend of C$0.04 per Share

16/04/2018 - 14:00

MARKHAM, Ontario, April 16, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]